Cargando…
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
The amyloid hypothesis has driven drug development strategies for Alzheimer's disease for over 20 years. We review why accumulation of amyloid-beta (Aβ) oligomers is generally considered causal for synaptic loss and neurodegeneration in AD. We elaborate on and update arguments for and against t...
Autores principales: | Morris, Gary P, Clark, Ian A, Vissel, Bryce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207354/ https://www.ncbi.nlm.nih.gov/pubmed/25231068 http://dx.doi.org/10.1186/s40478-014-0135-5 |
Ejemplares similares
-
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
por: Morris, Gary P., et al.
Publicado: (2018) -
Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer’s disease
por: Clark, I A, et al.
Publicado: (2015) -
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023) -
The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016) -
Inflammation-sleep interface in brain disease: TNF, insulin, orexin
por: Clark, Ian A, et al.
Publicado: (2014)